FDA Adverse Event Injury Summary report: N

INFINION 16

MDR report key: 17630172 · Received August 28, 2023

Report

Report Number
3006630150-2023-05102
Event Type
Injury
Date Received
August 28, 2023
Date of Event
August 7, 2023
Report Date
August 28, 2023
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
UDI-DI
08714729837145
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: UPN: M365SC231670E0, MODEL: SC-2316-70E, SERIAL: (B)(6), LOT: 7082629. PRODUCT FAMILY: UPN: M365SC231670E0, MODEL: SC-2316-70E, SERIAL: (B)(6), LOT: 7082657.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT A TRIAL SPINAL CORD STIMULATION (SCS) IMPLANT PROCEDURE. THE PATIENT WAS ADMINISTERED LOCAL ANESTHESIA DURING THE PROCEDURE. THE PHYSICIAN EXPERIENCED SIGNIFICANT DIFFICULTY WITH LEAD DRIVING AT THE ENTRY. SEVERE BLOCKAGES WERE NOTED BETWEEN THORACIC 12 TO THORACIC 10. THE PHYSICIAN WAS UNABLE TO ADVANCE PAST THORACIC 10. DURING THE PROCEDURE THE PATIENT SCREAMED AND JUMPED SUDDENLY ON THE TABLE. THE PHYSICIAN EXPLANTED THE LEADS, AND THE SURGERY WAS ABORTED. THE PATIENT HAD LIMITED FUNCTION AND MOVEMENT OF THEIR LEFT LEG AND EXPERIENCED INTENSE PAIN THAT SEEMED TO WORSEN. THE PATIENT WAS IMMEDIATELY SENT FOR A MAGNETIC RESONANCE IMAGING (MRI), WHICH RESULTED IN NO FINDINGS. PAIN INJECTION WAS ADMINISTERED ALONG WITH ORAL MEDICATION. THE TRIAL LEADS WILL NOT BE RETURNED AS THEY WERE DISCARDED AT THE MEDICAL FACILITY. IT WAS LATER REPORTED THAT THE PATIENT IS STABLE, HAS FULL FUNCTIONALITY OF THEIR LEG, JUST INTENSE RESIDUAL PAIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1703767 INFINION 16 STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION SC-2316-70E 7082343 08714729837145

Patients

Seq Age Sex Outcome Treatment
1 63 YR Female Required Intervention